68 related articles for article (PubMed ID: 23339446)
1. BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia.
Anderson MA; Huang DC; Roberts AW
Leuk Lymphoma; 2013 May; 54(5):909-11. PubMed ID: 23339446
[No Abstract] [Full Text] [Related]
2. Bax and Bak are required for apogossypolone, a BH3-mimetic, induced apoptosis in chronic lymphocytic leukemia cells.
Balakrishnan K; Aggarwal S; Wierda W; Gandhi V
Leuk Lymphoma; 2013 May; 54(5):1097-100. PubMed ID: 22866921
[No Abstract] [Full Text] [Related]
3. Development of Noxa-like BH3 mimetics for apoptosis-based therapeutic strategy in chronic lymphocytic leukemia.
Billard C
Mol Cancer Res; 2012 Jun; 10(6):673-6. PubMed ID: 22466256
[TBL] [Abstract][Full Text] [Related]
4. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
[TBL] [Abstract][Full Text] [Related]
5. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.
Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C
Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285
[TBL] [Abstract][Full Text] [Related]
7. MOMP in the absence of BH3-only proteins.
García Sáez AJ; Villunger A
Genes Dev; 2016 Apr; 30(8):878-80. PubMed ID: 27083995
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane.
O'Neill KL; Huang K; Zhang J; Chen Y; Luo X
Genes Dev; 2016 Apr; 30(8):973-88. PubMed ID: 27056669
[TBL] [Abstract][Full Text] [Related]
9. BCL-2 proteins and apoptosis: Recent insights and unknowns.
Edlich F
Biochem Biophys Res Commun; 2018 May; 500(1):26-34. PubMed ID: 28676391
[TBL] [Abstract][Full Text] [Related]
10. BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model.
Gérecová G; Kopanicová J; Jaká P; Běhalová L; Juhásová B; Bhatia-Kiššová I; Forte M; Polčic P; Mentel M
FEMS Yeast Res; 2013 Dec; 13(8):747-54. PubMed ID: 23991648
[TBL] [Abstract][Full Text] [Related]
11. The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics.
Karlberg M; Ekoff M; Huang DC; Mustonen P; Harvima IT; Nilsson G
J Immunol; 2010 Aug; 185(4):2555-62. PubMed ID: 20639495
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of RNA interference targeting BaxBak on apoptosis of human granulosa cells].
Li H; Zeng WS; Luo S; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2367-70. PubMed ID: 20034877
[TBL] [Abstract][Full Text] [Related]
13. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
14. [Effects of gossypol acetate on apoptosis in primary cultured cells from patients with lymphoid leukemia and its synergy with dexamethasone].
Cheng W; Zhao YQ; Li YM; Yang DJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):229-34. PubMed ID: 22541072
[TBL] [Abstract][Full Text] [Related]
15. BH3-only protein Bim inhibits activity of antiapoptotic members of Bcl-2 family when expressed in yeast.
Juhásová B; Mentel M; Bhatia-Kiššová I; Zeman I; Kolarov J; Forte M; Polčic P
FEBS Lett; 2011 Sep; 585(17):2709-13. PubMed ID: 21820438
[TBL] [Abstract][Full Text] [Related]
16. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
van Delft MF; Wei AH; Mason KD; Vandenberg CJ; Chen L; Czabotar PE; Willis SN; Scott CL; Day CL; Cory S; Adams JM; Roberts AW; Huang DC
Cancer Cell; 2006 Nov; 10(5):389-99. PubMed ID: 17097561
[TBL] [Abstract][Full Text] [Related]
17. A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species.
Verhaegen M; Bauer JA; Martín de la Vega C; Wang G; Wolter KG; Brenner JC; Nikolovska-Coleska Z; Bengtson A; Nair R; Elder JT; Van Brocklin M; Carey TE; Bradford CR; Wang S; Soengas MS
Cancer Res; 2006 Dec; 66(23):11348-59. PubMed ID: 17145881
[TBL] [Abstract][Full Text] [Related]
18. The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukemia.
Fegan C; Starczynski J; Pratt G; Pepper C
Leukemia; 2006 Aug; 20(8):1460-1. PubMed ID: 16761015
[No Abstract] [Full Text] [Related]
19. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.
Konopleva M; Contractor R; Tsao T; Samudio I; Ruvolo PP; Kitada S; Deng X; Zhai D; Shi YX; Sneed T; Verhaegen M; Soengas M; Ruvolo VR; McQueen T; Schober WD; Watt JC; Jiffar T; Ling X; Marini FC; Harris D; Dietrich M; Estrov Z; McCubrey J; May WS; Reed JC; Andreeff M
Cancer Cell; 2006 Nov; 10(5):375-88. PubMed ID: 17097560
[TBL] [Abstract][Full Text] [Related]
20. Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia.
Besbes S; Mirshahi M; Pocard M; Billard C
Blood Rev; 2015 Sep; 29(5):345-50. PubMed ID: 25887155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
